About Alison Burklund
Alison Burklund is co-founder and co-CEO of Nanopath, which develops diagnostic tests for pelvic and gynecologic infections. She is also a board director.
In 2022, she was Nanopath’s co-founder and chief technology officer. In 2024, she was its president and chief technology officer. Forbes included her on its 2023 30 Under 30 Healthcare list.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Alison Burklund in the role, so the role may have started earlier or lasted longer.
Nanopath Inc Current
Co-Founder, Co-CEO, Board Director
co-founder, President, and CTO
co-founder and CTO
2022 – Present · Cambridge, MA
Nanopath develops clinic-based molecular tests designed to return actionable infection results during one office visit.
Key Colleagues at Startups
The people Alison Burklund works with at each company, as listed on that company's latest Form D.
Nanopath Inc · Form D, Nov 13, 2026
Amogha Tadimety
Co-Founder, Co-CEO, Board Director
JC
Jeff Crowe
Board Director
Aaron Sandoski
Board Director